| Medical Mutual | Elzonris® (tagraxofusp-erzs) (Intravenous) | 2026-05-05 |
| Medical Mutual | Empliciti® (elotuzumab) (Intravenous) | 2026-05-05 |
| Medical Mutual | Enjaymo® (sutimlimab-jome) (Intravenous) | 2026-05-05 |
| Medical Mutual | Enhanced Oncology Value (Subcutaneous) (EOV) | 2026-05-05 |
| Medical Mutual | Exondys 51® (eteplirsen) (Intravenous) | 2026-05-05 |
| Medical Mutual | Izervay® (avacincaptad pegol) (Intravitreal) | 2026-05-05 |
| Medical Mutual | Oncology Value: Kyprolis® (carfilzomib) (Intravenous) (EOV) | 2026-05-05 |
| Medical Mutual | Lemtrada® (alemtuzumab) (Intravenous) | 2026-05-05 |
| Medical Mutual | Value: Lynozyfic™ (linvoseltamab-gcpt) (Intravenous) | 2026-05-05 |
| Medical Mutual | Ryplazim® (plasminogen, human-tvmh) (Intravenous) | 2026-05-05 |